{"contacts": [{"terms": [{"accession": "MS:1000586", "name": "contact name", "value": "Sander Piersma"}, {"accession": "MS:1000589", "name": "contact email", "value": "s.piersma@vumc.nl"}, {"accession": "MS:1000590", "name": "contact affiliation", "value": "OncoProteomics Laboratory, dept of Medical Oncology, VUmc Medical Center, Amsterdam, The Netherlands"}, {"accession": "MS:1002037", "name": "dataset submitter"}]}, {"terms": [{"accession": "MS:1002332", "name": "lab head"}, {"accession": "MS:1000586", "name": "contact name", "value": "Connie Ramona Jimenez"}, {"accession": "MS:1000589", "name": "contact email", "value": "c.jimenez@vumc.nl"}, {"accession": "MS:1000590", "name": "contact affiliation", "value": "OncoProteomics Laboratory, Dept of Medical Oncology, VU University Medical Center, Amsterdam, The Netherlands"}]}], "datasetFiles": [{"accession": "PRIDE:0000408", "name": "Search engine output file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/04/PXD006616/MaxQuant_pTyr_K562_H2228_SK_Mel28.zip"}, {"accession": "PRIDE:0000404", "name": "Associated raw file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/04/PXD006616/QE1_140414_OPL1013_IdR_CvA_pTyrIP_A.raw"}, {"accession": "PRIDE:0000404", "name": "Associated raw file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/04/PXD006616/QE1_140414_OPL1013_IdR_CvA_pTyrIP_A_140415105958.raw"}, {"accession": "PRIDE:0000404", "name": "Associated raw file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/04/PXD006616/QE1_140414_OPL1013_IdR_CvA_pTyrIP_B.raw"}, {"accession": "PRIDE:0000404", "name": "Associated raw file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/04/PXD006616/QE1_140414_OPL1013_IdR_CvA_pTyrIP_B_140415130214.raw"}, {"accession": "PRIDE:0000404", "name": "Associated raw file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/04/PXD006616/QE1_140414_OPL1013_IdR_CvA_pTyrIP_C.raw"}, {"accession": "PRIDE:0000404", "name": "Associated raw file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/04/PXD006616/QE1_140414_OPL1013_IdR_CvA_pTyrIP_C_140415150423.raw"}, {"accession": "PRIDE:0000404", "name": "Associated raw file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/04/PXD006616/QE1_140414_OPL1013_IdR_CvA_pTyrIP_D.raw"}, {"accession": "PRIDE:0000404", "name": "Associated raw file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/04/PXD006616/QE1_140414_OPL1013_IdR_CvA_pTyrIP_D_140415170635.raw"}, {"accession": "PRIDE:0000404", "name": "Associated raw file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/04/PXD006616/QE1_140414_OPL1013_IdR_CvA_pTyrIP_E.raw"}, {"accession": "PRIDE:0000404", "name": "Associated raw file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/04/PXD006616/QE1_140414_OPL1013_IdR_CvA_pTyrIP_E_140415190842.raw"}, {"accession": "PRIDE:0000404", "name": "Associated raw file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/04/PXD006616/QE1_140414_OPL1013_IdR_CvA_pTyrIP_F.raw"}, {"accession": "PRIDE:0000404", "name": "Associated raw file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/04/PXD006616/QE1_140414_OPL1013_IdR_CvA_pTyrIP_F_140415211055.raw"}, {"accession": "PRIDE:0000410", "name": "'Other' type file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/04/PXD006616/Supplementary phosphopeptide table pTyr_K562_H2228_SK_Mel28.xlsx"}, {"accession": "PRIDE:0000410", "name": "'Other' type file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/04/PXD006616/Supplementary phosphosite table pTyr_K562_H2228_SK_Mel28.xlsx"}, {"accession": "PRIDE:0000408", "name": "Search engine output file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/04/PXD006616/MaxQuant_pTyr_HCC827_ER3.zip"}, {"accession": "PRIDE:0000404", "name": "Associated raw file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/04/PXD006616/QE2_131211_OPL1013_RH_HCC_pTyrIP_A_02.raw"}, {"accession": "PRIDE:0000404", "name": "Associated raw file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/04/PXD006616/QE2_131211_OPL1013_RH_HCC_pTyrIP_A_02_131211093759.raw"}, {"accession": "PRIDE:0000404", "name": "Associated raw file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/04/PXD006616/QE2_131211_OPL1013_RH_HCC_pTyrIP_G_05.raw"}, {"accession": "PRIDE:0000404", "name": "Associated raw file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/04/PXD006616/QE2_131211_OPL1013_RH_HCC_pTyrIP_G_05_131211154413.raw"}, {"accession": "PRIDE:0000410", "name": "'Other' type file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/04/PXD006616/Supplementary table phosphopeptides pTyr HCC827-ER3.xlsx"}, {"accession": "PRIDE:0000410", "name": "'Other' type file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/04/PXD006616/Supplementary table phosphosites pTyr HCC827-ER3.xlsx"}, {"accession": "PRIDE:0000408", "name": "Search engine output file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/04/PXD006616/MaxQuant_pTyr_HCC827 parental.zip"}, {"accession": "PRIDE:0000404", "name": "Associated raw file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/04/PXD006616/QE3_170131_OPL1013_RdH_PtyrIP_HCC827_A.raw"}, {"accession": "PRIDE:0000404", "name": "Associated raw file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/04/PXD006616/QE3_170131_OPL1013_RdH_PtyrIP_HCC827_B.raw"}, {"accession": "PRIDE:0000410", "name": "'Other' type file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/04/PXD006616/Supplemental table phosphopeptides pTyr HCC827 parental cell line.xlsx"}, {"accession": "PRIDE:0000410", "name": "'Other' type file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/04/PXD006616/Supplemental table phosphosites pTyr HCC827 parental cell line.xlsx"}, {"accession": "PRIDE:0000408", "name": "Search engine output file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/04/PXD006616/MaxQuant_TiOx_data.zip"}, {"accession": "PRIDE:0000404", "name": "Associated raw file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/04/PXD006616/QE1_160617_OPL1013_RdH_TiOx_oncogene_cell_lines_A.raw"}, {"accession": "PRIDE:0000404", "name": "Associated raw file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/04/PXD006616/QE1_160617_OPL1013_RdH_TiOx_oncogene_cell_lines_B.raw"}, {"accession": "PRIDE:0000404", "name": "Associated raw file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/04/PXD006616/QE1_160617_OPL1013_RdH_TiOx_oncogene_cell_lines_C.raw"}, {"accession": "PRIDE:0000404", "name": "Associated raw file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/04/PXD006616/QE1_160617_OPL1013_RdH_TiOx_oncogene_cell_lines_D.raw"}, {"accession": "PRIDE:0000404", "name": "Associated raw file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/04/PXD006616/QE1_160617_OPL1013_RdH_TiOx_oncogene_cell_lines_E.raw"}, {"accession": "PRIDE:0000404", "name": "Associated raw file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/04/PXD006616/QE1_160617_OPL1013_RdH_TiOx_oncogene_cell_lines_F.raw"}, {"accession": "PRIDE:0000404", "name": "Associated raw file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/04/PXD006616/QE1_160617_OPL1013_RdH_TiOx_oncogene_cell_lines_G.raw"}, {"accession": "PRIDE:0000404", "name": "Associated raw file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/04/PXD006616/QE1_160617_OPL1013_RdH_TiOx_oncogene_cell_lines_H.raw"}, {"accession": "PRIDE:0000410", "name": "'Other' type file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/04/PXD006616/Supplementary table phosphopeptides TiOx.xlsx"}, {"accession": "PRIDE:0000410", "name": "'Other' type file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/04/PXD006616/Supplementary table phosphosites TiOx.xlsx"}], "description": "As a large proportion of current targeted cancer therapies is based on specific (tyrosine) kinase inhibitors, uncovering the identity of hyperactive kinases at work in tumors is crucial for proper treatment selection. A major challenge in phosphoproteomic data analysis is to relate kinases to the extent and magnitude of their phosphorylation 'footprint', and to rank them accordingly in order to single out kinases that are crucial for tumor growth in individual patients. Previous approaches have either zeroed in on phosphorylation of kinases themselves as a read-out of kinase activity, or focused on inferring kinase activities from the phosphorylation of their (supposed) substrates. Here, we combine both kinase-centric and substrate-centric analyses. We present a computational pipeline called Integrative Inferred Kinase Activity (INKA) scoring that integrates the observed abundance of phosphopeptides derived from (i) kinases as a whole, (ii) their kinase activation loop segments, (iii) proteins deduced to be kinase substrates based on prior experimental knowledge of kinase-substrate relationships, and/or (iv) kinase substrates predicted by the sequence motif- and network-based NetworKIN algorithm. As a proof of concept, applying this pipeline to the analysis of phosphoproteomic data on seven different oncogene-driven cancer cell lines highlighted the high, top ranking inferred activity of known driver kinases in these cells. This demonstrates the potential of label-free MS-based phosphoproteomics combined with dedicated data analysis for identifying (hyper)active kinases that, in potential future applications to tumors, may be selected for targeted inhibition in a personalized treatment setting.", "fullDatasetLinks": [{"accession": "PRIDE:0000411", "name": "Dataset FTP location", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/04/PXD006616"}, {"accession": "MS:1001930", "name": "PRIDE project URI", "value": "http://www.ebi.ac.uk/pride/archive/projects/PXD006616"}], "identifiers": [{"accession": "MS:1001919", "name": "ProteomeXchange accession number", "value": "PXD006616"}], "instruments": [{"accession": "MS:1001911", "name": "Q Exactive"}], "keywords": [{"accession": "MS:1001925", "name": "submitter keyword", "value": "Human, Tyrosine kinase, phosphokinase ranking, label-free, single-shot, phosphoproteomics"}, {"accession": "MS:1001926", "name": "curator keyword", "value": "Technical"}, {"accession": "MS:1001926", "name": "curator keyword", "value": "Biomedical"}], "modifications": [{"accession": "MOD:00696", "name": "phosphorylated residue"}, {"accession": "MOD:00425", "name": "monohydroxylated residue"}, {"accession": "MOD:00394", "name": "acetylated residue"}, {"accession": "MOD:00397", "name": "iodoacetamide derivatized residue"}], "publications": [{"terms": [{"accession": "MS:1000879", "name": "PubMed identifier", "value": "30979792"}, {"accession": "PRIDE:0000400", "name": "Reference", "value": "Beekhof R, van Alphen C, Henneman AA, Knol JC, Pham TV, Rolfs F, Labots M, Henneberry E, Le Large TY, de Haas RR, Piersma SR, Vurchio V, Bertotti A, Trusolino L, Verheul HM, Jimenez CR. INKA, an integrative data analysis pipeline for phosphoproteomic inference of active kinases. Mol Syst Biol. 2019 15(4):e8250"}]}], "species": [{"terms": [{"accession": "MS:1001469", "name": "taxonomy: scientific name", "value": "Homo sapiens (Human)"}, {"accession": "MS:1001467", "name": "taxonomy: NCBI TaxID", "value": "9606"}]}], "title": "INKA, an integrative analysis pipeline for inference of hyperactive phosphokinases in mass spectrometry-based phosphoproteomics data"}